+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

These are the 25 stocks to bet against on a successful COVID-19 vaccine, according to JPMorgan

Oct 24, 2020, 00:57 IST
Business Insider
Drew Angerer/Getty Images
  • With a successful COVID-19 vaccine on the horizon, some stocks may fare better than others.
  • According to JPMorgan, investors should look to bet against a handful of stocks that have experienced increased momentum in their business amid the COVID-19 pandemic.
  • Once a successful COVID vaccine is distributed and administered, it could lead to a slowdown in growth for a number of businesses as a return to normal activity ensues.
  • Here are 25 stocks traders should bet against once a successful COVID-19 vaccine is disbursed, according to JPMorgan.
  • Visit Business Insider's homepage for more stories.
Advertisement

The development of a successful COVID-19 vaccine could have wide-ranging implications on a basket of stocks that saw a surge in growth amid the pandemic.

That's according to a Friday note from JPMorgan, which put together a list of 25 stocks traders should bet against once a COVID-19 vaccine is distributed and administered to the population.

"This is a list of stocks that are in the upper echelon of Momentum and have crowded positioning, that could see the second derivative of their profit growth decrease as consumer/corporate activity normalizes," JPMorgan explained.

On the flip side, Goldman Sachs offered six stocks on Friday that could benefit from the distribution and administration of a successful COVID-19 vaccine.

The JPMorgan basket of stocks should be viewed as a tactical opportunity to express a bearish view on the catalyst of a COVID-19 vaccine, and should not be viewed as a fundamental call on the company.

Advertisement

Here are 25 stocks traders should bet against once a successful COVID-19 vaccine is disbursed, according to JPMorgan.

Read more: Don't put too much energy into predicting the result -- 5 key tips for clients from strategists at JPMorgan's $1.9 trillion asset management arm with less than two weeks to go to the election

1. Novavax

YTD Performance: 2190%

2. Zoom Video

Advertisement

YTD Performance: 654%

3. Overstock.com

YTD Performance: 887%

4. Fiverr International

YTD Performance: 583%

Advertisement

5. Peloton Interactive

YTD Performance: 338%

6. Moderna

YTD Performance: 250%

7. Stamps.com

Advertisement

YTD Performance: 206%

8. Wayfair

YTD Performance: 199%

9. Vista Outdoor

YTD Performance: 171%

Advertisement

10. Bandwith

YTD Performance: 167%

Read More: MORGAN STANLEY: Buy these 61 stocks that will offer major earnings-driven upside following an imminent 10% market sell-off

11. Boston Beer Company

YTD Performance: 141%

Advertisement

12. Chegg.com

YTD Performance: 127%

13. Logitech International

YTD Performance: 95%

14. Big Lots

Advertisement

YTD Performance: 81%

15. Grubhub

YTD Performance: 66%

16. Chipotle Mexican Grill

YTD Performance: 63%

Advertisement

17. Yeti Holdings

YTD Performance: 47%

18. Scotts Miracle-Gro

YTD Performance: 47%

19. K12

Advertisement

YTD Performance: 40%

Read More: Big investors pay thousands of dollars for Danielle DiMartino Booth's research. The former Fed advisor explains how the central bank has distorted markets - and shares 2 areas where analytical traders can still find returns.

20. Equinix

YTD Performance: 38%

21. Clorox

Advertisement

YTD Performance: 38%

22. Costco Wholesale

YTD Performance: 29%

23. Digital Realty Trust

YTD Performance: 29%

Advertisement

24. Central Garden & Pet

YTD Performance: 26%

25. American Well

Performance since IPO: 25%

JPMorgan
Next Article